Ebastine Sandoz 20 mg orodisp. tabl.

Țară: Belgia

Limbă: engleză

Sursă: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Cumpara asta acum

Ingredient activ:

Ebastine 20 mg

Disponibil de la:

Sandoz SA-NV

Codul ATC:

R06AX22

INN (nume internaţional):

Ebastine

Dozare:

20 mg

Forma farmaceutică:

Orodispersible tablet

Compoziție:

Ebastine 20 mg

Calea de administrare:

Oral use

Zonă Terapeutică:

Ebastine

Rezumat produs:

CTI code: 446480-04 - Pack size: 30 - Commercialisation status: YES - FMD code: 07613421001445 - CNK code: 3121225 - Delivery mode: Medical prescription; CTI code: 446480-03 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 446480-02 - Pack size: 15 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 446480-01 - Pack size: 10 - Commercialisation status: YES - FMD code: 07613421001438 - CNK code: 3121217 - Delivery mode: Medical prescription; CTI code: 446480-08 - Pack size: 100 - Commercialisation status: YES - FMD code: 07613421001421 - CNK code: 3121241 - Delivery mode: Medical prescription; CTI code: 446480-07 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 446480-06 - Pack size: 50 - Commercialisation status: NO - FMD code: 07613421001452 - CNK code: 3121233 - Delivery mode: Medical prescription; CTI code: 446480-05 - Pack size: 40 - Commercialisation status: NO - Delivery mode: Medical prescription

Statutul autorizaţiei:

Commercialised: Yes

Data de autorizare:

2014-01-09

Documente în alte limbi

Prospect Prospect germană 01-07-2022
Prospect Prospect franceză 01-07-2022
Caracteristicilor produsului Caracteristicilor produsului franceză 01-07-2022
RMP RMP franceză 10-11-2022
Prospect Prospect olandeză 01-07-2022
Caracteristicilor produsului Caracteristicilor produsului olandeză 01-07-2022
RMP RMP olandeză 10-11-2022

Căutați alerte legate de acest produs